NEWS | March 5, 2020

UC Davis Comprehensive Cancer Center launches new Adolescent and Young Adult oncology program


UC Davis Comprehensive Cancer Center this week launched a new Adolescent and Young Adult oncology program. The program will provide coordinated services to advance the care of adolescents and young adults with cancer.

Teen Cancer America has provided funding for the launch of the UC Davis Adolescent and Young Adult oncology program. Teen Cancer America has provided funding for the launch of the UC Davis Adolescent and Young Adult oncology program.

Adolescent and young adult cancer patients face unique challenges. They may be working toward completing high school, applying to college or pursing job training. They’re often beginning their careers, and may be starting a family or planning for one. Cancer makes all of these more difficult and more complicated.

The Adolescent and Young Adult oncology program (AYA) serves patients age 15-39, whether in active treatment or post-therapy survivorship. Through the AYA oncology program at UC Davis, patients also get access to counseling and care that helps them manage the milestones and challenges that come with being a cancer patient at such a pivotal time of life. The program will include psychosocial and supportive care, fertility preservation, genetic testing and survivorship support.

“Only 6 to 7% of all newly diagnosed cancer patients in the U.S. are adolescents and young adults so they often fall through the cracks. This program will create a supportive oncology program for these patients, providing not only the highest level of care as they are battling cancer, but addressing their social, spiritual and emotional needs. It’s a whole-patient care model,” said Marcio Malogolowkin, chief of pediatric hematology-oncology. “I hope our program will work as a model of care for all patients, training for future generations of care givers and for the development of novel research.”

Teen Cancer America, a nonprofit organization that develops specialized facilities and services for teens and young adults with cancer, will help fund the new program.

"It is a privilege to be partnering with such a prestigious health system as UC Davis in this vitally important initiative. Professor Malogolowkin and his team are world class. Adolescents and young adults with cancer will benefit from improved outcomes as a result of this essential program that is at the forefront of an emerging specialty,” said Simon Davies, executive director of Teen Cancer America. “We are grateful to the UC Davis leadership for having the foresight to join Teen Cancer America's pioneering movement to transform the treatment landscape for every young person with cancer in the U.S."

UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. Its specialists provide compassionate, comprehensive care for more than 10,000 adults and children every year, and access to more than 150 clinical trials at any given time. Its innovative research program engages more than 280 scientists at UC Davis who work collaboratively to advance discovery of new tools to diagnose and treat cancer. Patients have access to leading-edge care, including immunotherapy and other targeted treatments. Its Community Outreach and Education program addresses disparities in cancer outcomes across diverse populations, and the center provides comprehensive education and workforce development programs for the next generation of clinicians and scientists. Through the Cancer Care Network, UC Davis partners with hospitals and clinical centers throughout the Central Valley and Northern California communities to offer patients expert care close to home. For more information, visit